Outcomes from the cancer registries in scientific literature

Our company provides technological and analytical background for clinical registries of the Czech Society for Oncology, which have been established for the monitoring of effectiveness and safety of targeted cancer therapy. Similarly to previous years, data analyses of these registries were used as a background for a series of articles published in international medical journals.

Considering the impact factor value, the most interesting outcome is undoubtedly the RENIS registry-based paper entitled Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis, published in European Urology (IF 16,265).

The higher number of outputs, however, arose from the TULUNG registry (6 articles), 2 papers were based on the RENIS registry and other 2 papers on the CORECT registry.

CORECT registry:

RENIS registry:

TULUNG registry:

4. 5. 2017


The Institute of Biostatistics and Analyses is an investigator of the project “Extending services portfolio of an information system for the data management in clinical research”. The project is supported by the OP EIC from the European Union funds.

Main objective of the project is the development of a platform for composition of information systems focused on data management and data mining in the field of pharmaceutical industry and life sciences. Offer of digital services based on a developed and validated information system will make reliable analytical models accessible to the companies for their decision-making and precise information sources for regulatory bodies. The project steps out of a laboratory environment of clinical trials and focuses on the evidence supported by real-world data.

Institute of Biostatistics and Analyses, Ltd.